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1. Introduction 
It is now well establisIled that, in skeletal muscle, 
the acetylcholine receptor (AChR) which is localized 
at the endplate (junctional AChR) differs from the 
receptor distributed outside the endplate (extra- 
junctional AChR) by: isoelectric point [ 11, mean 
channel open time [2-41, immunological reactivity 
[5,6] and metabolic stability. The extrajunctional 
AChR is degraded in vivo with a half-time of -20 h, 
whereas the degradation of the junctional AChR 
occurs >lO-times slower [7-91. At the molecular 
level, these differences might be accounted for either 
by different primary structures, or by the existence 
of several forms of the AChR which would derive 
from each other, for instance, as a result of either a 
covalent modification [lo] or of an association with 
different membrane components (reviewed [ 1 I]). In 
order to investigate this question, we have been 
concerned in the past few years with the factors, or 
conditions, which may lead to a ~lodification of the 
structural properties of the AChR protein in the 
membrane, using the AChR from fish electric organ 
as a model system [12-141. 
The AChR-rich membranes prepared from the 
electric organ of Torpedo m~rmorata contain two 
major polypeptide chains of app. mol. wt 40 000 
(40 k) and 43 000 (43 k) and two minor ones of app. 
mol. wt 50 000 (50 k) and 66 000 (66 k) [15]. 
Unambiguously, the 40 k chain carries the acetyl- 
choline binding site. The significance of the 43 k chain 
is still rather unclear, This polypeptide can be removed 
from the AChR-rich membranes by pH 11 treatment 
without changing most of the known functional 
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properties of the AChR protein [ 161. It does not 
comigrate with Torpedo actin and its amino acid 
composition does not resemble that of any known 
cytoskeletal protein [17,18] but [19]. 
Here we report experiments carried out on the 
susceptibility to heat inactivation of AChR from 
T. marmorata. They reveal that this property may 
change as a consequence of intrinsic or extrinsic 
modifications of the membrane-bound AChR and 
therefore can be used as a criterion to reveal minor 
differences in the structure of the AChR molecule or 
of its close environment. 
2. Materials and methods 
2.1 .AChR-rich membrane fragments from Torpedo 
marmorata: Treatment by alkaline and acid pH 
AChR-rich membrane fragments were prepared 
essentiaily by the method in [ 151 as modified (201. 
The alkaline pH treatment of the membranes was 
done as follows: the membrane fragments resuspended 
in distilled water at 0.25 mg protein/ml were supple- 
mented with 0.1 M NaOH to the desired pH, allowed 
to stand at room temperature for 60 min, centrifuged 
in a Beckman airfuge for 2 min and the pellet 
resuspended in Torpedo physiological saline solution. 
The supernatants were neutralized with 0.1 M HCl 
and used as the source of the 43 k polypeptide. The 
acid pH treatment of the membranes was performed 
with a 0.5 mg protein~ml suspension of membrane 
fragments and 0.1 M acetate or Tris-HCI buffer at 
0°C for 10 h; membranes were then washed as above. 
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2.2. Label&g of the 43 k polypeptide with 35S 
The 43 k polypeptide was labelled with the 
diazonium salt of [35S]sulfanilic acid, synthesized by 
the procedure in 1211. The supernatant resulting from 
the pH 11 treatment of receptor enriched membranes 
containing about 0.06 mg 43 k protein/ml was 
adjusted to ptl 9.1 with 0.05 M NaCl-0.025 M 
borate buffer, added to tubes containing the 
diazonium salt of sulfanilic acid giving 7 X 1 OW6 M 
final cont., allowed to stand at 4°C for 10 min, then 
dialyzed extensively against reaction buffer. 
2.3. Enzymatic treatments of the AChR 
AChR-rich membranes were solubilized with 1% 
Triton X-100 at 0.5 mg protein/ml. The solution was 
centrifuged and the supernatant adjusted to pH 7.8 
with 0.1 M Tris-HCl, and incubated with 1 unit/l111 
of alkaline phosphatase from Escherichia eoli (type 
II-R, Sigma) at 4’C for 1 h. The treatment with 200 
units/ml of phospholipase AZ from porcine pancreas 
was done under the same conditions except that the 
incubation was carried out at 3’7’C and that 2 mM 
CaC12 was added to the incubation mixture. The treat- 
ment with a mixture of exoglycosidases and endo- 
glycosidases from Streptococcus pneumoniae [22] 
was performed at 37°C and for 1 h. The enzymes 
used here did not contain detectable amount of 
protease activity. 
3. Results and discussion 
3.1. Alkaline treatment increases the susceptibility to 
heat inactivation of the membrane-bound AChR 
As reported [ 161 alkaline treatment of AChR- 
rich membranes caused the release of the 43 k poly- 
peptide from the membrane (fig.lB,C). This release 
took place, as a sharp transition, at pH 10.4-10.8 
under conditions where little inactivation of the 
AChR sites, as determined by followirlg the ability 
to bind r2’ I-labelled a-bungarotoxin, occurred. It is 
now well established that the alkaline treatment 
does not significantly alter the allosteric transitions of 
the AChR protein and their regulation by non-com- 
petitive blocking agents such as local anesthetics 
116,231. In order to test if other molecular properties 
of the receptor protein were modified by the treat- 
ment, the extent of heat inactivation of the AChR 
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Fig.1. Effect of alkaline pH treatment of AChR-rich mem- 
branes on the release of the 43 k polypeptide, on ‘2*1-labelled 
cu-bungarotoxin binding and on the thermal stability of the 
AChR. (A) AChR-rich membranes were exposed to the 
indicated pH values in section 2 and centrifuged. The “‘I- 
labelled a-bungarotoxin binding and heat inactivation of the 
AChR were determined on the resuspended pellet. ’ *’ I- 
labelled a-bungarotoxin binding was determined by measuring 
the retention of the ‘Z51-labe11ed ~-bungarotox~n - nlembrane 
complex on Millipore Filters (HA-0.45) and expressed as the 
percentage of the value for untreated membranes. The heat 
inactivation was determined by following the residual 
‘ZSI-labelled ol-bungarotoxin binding of the membranes after 
7 min incubation at 6O”C, and is expressed as the percentage 
of the value for untreated membranes. (B) Release of the 
43 k polypeptide from AChR-rich membranes as a function 
of pH. The quantification of the 43 k polypeptide was per- 
formed by weighing the tracing paper of a scan of Coomassie 
stained SDS-polyacrylamide gels presented in (C). (C) 
Protein pattern of the membranes treated at: (1) pH 9.7; 
(2) pH 10.1; (3) pH 10.4; (4) pH 10.8; (5) pH 11.0; (6) 
pH 11.2. 
protein at 60°C was determined (see legend of fig.1) 
after alkaline treatment and neutralization of the 
membrane suspension. Figure 1A shows that, as a 
consequence of the alkaline treatment, the loss of 
lz5 I-labelled ~-bungarotox~n binding sites at 60°C 
increased markedly and that the enhanced susceptibility 
to inactivation grossly paralleled the release of the 
80 
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Fig.2. Reassociation of the 43 k polypeptide to alkaline-treated AChR-rich membranes. (A) AChR-rich membranes treated at 
pH 11 as in section 2 were centrifuged, suspended either in lo-” M NaOH (pH 11) (0 -0) or in its own supernatant (A-- A) 
containing the 43 k polypeptide, and neutralized with 0.1 M HCl. After 10 h, the membranes were spun down, resuspended in 
Torpedo physiological saline solution and the time course of heat inactivation of ol-bungarotoxin binding determined as in fig.1. 
The time course of heat inactivation of untreated membranes, is also presented (o-- 0). (B) Various amounts of 35S-labelled 
43 k polypeptide (-250 cpm/Mg) were added to test tubes containing either alkaline-treated membranes (0 ---•), or untreated 
control membranes (o --o), both containing 40 pmol ol-bungarotoxin sites, or to tubes without membranes (A --A). Tubes 
were incubated at room temperature for 10 h. Membraneassociated radioactivity was determined by filtering the samples through 
Millipore filters (HA-0.45), drying the filters, and counting in Toluene-PPO scintillator with a liquid scintillation counter. 
43 k polypeptide. Conversely, the thermal stability 
was partially regained when a supernatant containing 
the 43 k protein was mixed with alkaline-treated 
membranes, and subsequently neutralized (fig.2A). 
Under the same conditions the binding of 35S-labelled 
43 k polypeptide was shown to occur with the 
alkaline-treated membranes, but not with native, 
untreated membranes (fig.2B). The simplest inter- 
pretation of this data is that the association of some 
factor, presumably the 43 k protein, with the AChR- 
rich membranes stabilizes the AChR protein against 
heat inactivation. 
3.2. Acid pH treatment increases the susceptibility to 
heat inactivation of the membrane-bound AChR 
Mild acid pH treatment, contrary to the exposure 
to alkaline pH, does not significantly modify the 
polypeptide chain composition of the AChR-rich 
membranes [24]. Nevertheless, incubation of the 
AChR-rich membranes at an acid pH, where little, if 
any, loss of a-toxin binding sites occurred, caused a 
marked increase in susceptibility to heat inactivation 
(fig.3). For example, exposure of the AChR-rich 
membranes at pH 5.5 for 5 days did not result in any 
significant loss of ‘251-labelled a-bungarotoxin 
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Fig.3. Effect of acid pH treatment of AChR-rich membranes 
on ‘251-labelkl ol-bungarotoxin binding and on the thermal 
stability of the AChR. AChR-rich membranes were exposed 
to the indicated pH as in section 2. *251-labelled a-bungaro- 
toxin binding and thermal stability of AChR were determined 
as in fig.1. 
binding, hut the rate of inactivation of the AChR 
protein at (iO*C increased by a factor of --5. When 
alkaline-treated membranes were submitted tu the 
acid treatment, an increased susceptibility to heat 
inactivation was still noticed (fig.4A). In other words, 
the effects of alkaline and acid treatments on the 
thermal stability of the membrane-bound AChR were 
additive and therefore did not affect rhe same mem- 
brane target. 
3.3. The increased susceptibiIitJI to heat inuctivation 
caused by exposure of the AChR-rich membranes 
to acid pH ren~ains after s~~~b~~i~atio~ of the 
membrane by Tpito~ X-I 00 
The effects of the considered pH treatments may 
be interpreted on the basis of a change of the local 
environment of the receptor protein in the mem- 
brane and (or) of an intrinsic modification of the 
receptor molecule. To distinguish between these 
alternatives the thermal stability of the receptor 
protein was investigated after dissolution by Triton 
X-100 of the acid or alkaline-treated membranes. As 
shown in fig.4B the receptor protein solubilized 
from alkaline-treated membranes exhibited the same 
thermal stability as the receptor protein extracted 
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Fig.4. Effect of various treatments of the ACbR-rich mem- 
branes on the thermal stability of the AChR. (A) The time 
for a 50% decrease of ‘251-labelled n-bungarotoxin binding 
at 60°C was determined with AChR-rich membranes: (1) 
without treatment; (2) after treatment at pti 11; (3) after 
treatment at plI 5.5; (4) after treatment at pH 5.5, then at 
pH 1 I. Bar length = standard deviation. (B) The time for 50% 
decrease of ‘251-labelled a-bungarotoxin binding at 49°C was 
determined by a DEAE filter assay [ 291 on 1% Triton X-100 
solubitized AChR from the same AChR-rich membranes as 
for: (I) A-l; (2) A-2; (3) A-3; {4j A-4; (5) untreated mem- 
branes were solubilized in 1% Triton X-100 and treated with 
I unit/ml of alkaline phosphatase as in section 2; (6) pH 5 S- 
treated membranes were snlubilized in 1% Triton X-100 and 
treated with 1 unit/ml of’alkaline phosphatase as in section 2. 
from native membranes. This was not unexpected, 
since Triton X-100 is known to dissociate the 43 k 
and the AChR protein [17]. On the other hand, in 
Triton X-100 extracts of acid pH-treated membranes, 
the AChR was still more susceptible to heat inactiva- 
tion than in similar extracts of native membranes, 
These results are consistent with the ~~iter~re~tion 
that the effect of alkaline-treatment results from the 
elimination of the 43 k polypeptide rather than from 
an intrinsic modification of the receptor protein. In 
fact, this last possibility must be considered in the 
case of the acid pH treatment. 
3.4. Effect of various enzymatic treatments on the 
susceptibility of the AChR to heat inactivatio?l 
Since lipids and polysaccharides might still be 
associated with the AChR after dissolution by Triton 
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X-100, the effect of enzymes known to attack these 
molecules was tested on the Triton X-100 solubilized 
AChR-receptor. Though phospholipase A* treatment 
was reported to alter the binding properties of the 
AChR protein [25], it did not cause any significant 
change in the thermal stability of the AChR. A mix- 
ture of exo- and endoglycosidases, which was effective 
in modifying the electrophoretic mobility of the 
66 k polypeptide, did not affect the thermal stability 
of the AChR. On the other hand, treatment of the 
Triton X-100 extracted AChR with Escherichia coli 
alkaline phosphatase, which is known to dephosphoryl- 
ate phosphoproteins [26,27], increased its SUS- 
ceptibility to heat inactivation (fig.4B). Interestingly, 
the phosphatase was no longer effective when the 
AChR was extracted from acid pH treated membranes 
(fig.4B). This suggests that the exposure to acid pH 
and the phosphatase treatment have the same effect, 
i.e., cause a dephosphorylation of a phosphopeptide(s) 
present in the preparation of soluble AChR protein 
and, as a consequence, increase the susceptibility to 
heat inactivation of the AChR protein. 
4. Conclusion 
These results demonstrate that factors, or condi- 
tions, which do not significantly m.Jdify the binding 
of a-bungarotoxin to the membrane-bound AChR 
may modify its thermal stability. Among them, one 
may distinguish between ‘extrinsic’ factors, like the 
43 k protein, present in the close environment, or 
directly associated with the AChR in the membrane, 
and ‘intrinsic’ modifications of the receptor molecule 
such as a phosphorylation [ 14,281. 
These experiments further show that the determi- 
nation of the thermal stability of the AChR in vitro 
might be a useful method to investigate the discrete 
differences of structure existing between extra- and 
subsynaptic AChR and to study their evolution 
during synapse formation. 
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